U
Cognetivity Neurosciences Ltd.
CGN
CNSX
E
Sell
1/22/2025Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to E+ from E on 1/22/2025 due to an increase in the volatility index and total return index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to E+ from E on 1/22/2025 due to an increase in the volatility index and total return index.
E
Sell
1/6/2025Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E from E+ on 1/6/2025 due to a decline in the volatility index, growth index and solvency index. The quick ratio declined from 0.04 to 0.04, debt to equity increased from -0.1 to -0.09, and earnings per share declined from -$0.0167 to -$0.017.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E from E+ on 1/6/2025 due to a decline in the volatility index, growth index and solvency index. The quick ratio declined from 0.04 to 0.04, debt to equity increased from -0.1 to -0.09, and earnings per share declined from -$0.0167 to -$0.017.
E
Sell
11/6/2023Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E+ from D- on 11/6/2023 due to a decline in the volatility index, total return index and growth index.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E+ from D- on 11/6/2023 due to a decline in the volatility index, total return index and growth index.
D
Sell
10/20/2023Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D- from E+ on 10/20/2023 due to an increase in the volatility index and valuation index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D- from E+ on 10/20/2023 due to an increase in the volatility index and valuation index.
E
Sell
10/4/2023Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E+ from D- on 10/4/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.18 to 0.04, and debt to equity increased from -0.12 to -0.1.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E+ from D- on 10/4/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.18 to 0.04, and debt to equity increased from -0.12 to -0.1.
D
Sell
9/29/2023Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D- from E+ on 9/29/2023 due to an increase in the volatility index and total return index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D- from E+ on 9/29/2023 due to an increase in the volatility index and total return index.
E
Sell
9/13/2023Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E+ from D- on 9/13/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.44 to 0.18, and debt to equity increased from -0.13 to -0.12.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E+ from D- on 9/13/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.44 to 0.18, and debt to equity increased from -0.13 to -0.12.
D
Sell
3/14/2023Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 03/14/2023.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
12/19/2022Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 12/19/2022 due to a major increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.08 to 0.94, and operating cash flow increased 36.02% from -$264 to -$168.9.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 12/19/2022 due to a major increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.08 to 0.94, and operating cash flow increased 36.02% from -$264 to -$168.9.
D
Sell
6/30/2022Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 6/30/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.29 to 0.24.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 6/30/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.29 to 0.24.
D
Sell
5/5/2022Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 05/05/2022.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 4/20/2022 due to a decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0117 to -$0.0674, EBIT declined 435.01% from -$864 to -$4.62M, and operating cash flow declined 9.42% from -$714.8 to -$782.1.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 4/20/2022 due to a decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0117 to -$0.0674, EBIT declined 435.01% from -$864 to -$4.62M, and operating cash flow declined 9.42% from -$714.8 to -$782.1.
D
Sell
11/23/2021Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index and valuation index. Operating cash flow declined 43.53% from -$498 to -$714.8, earnings per share declined from -$0.0098 to -$0.0117, and EBIT declined 8.01% from -$799.9 to -$864.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index and valuation index. Operating cash flow declined 43.53% from -$498 to -$714.8, earnings per share declined from -$0.0098 to -$0.0117, and EBIT declined 8.01% from -$799.9 to -$864.
D
Sell
10/28/2020Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 10/28/2020 due to a large increase in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 10/28/2020 due to a large increase in the total return index and volatility index.
D
Sell
9/30/2020Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 9/30/2020 due to a significant decline in the solvency index, growth index and valuation index. EBIT declined 361.38% from -$98.9 to -$456.3, earnings per share declined from -$0.0025 to -$0.0081, and the quick ratio declined from 0.57 to 0.12.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 9/30/2020 due to a significant decline in the solvency index, growth index and valuation index. EBIT declined 361.38% from -$98.9 to -$456.3, earnings per share declined from -$0.0025 to -$0.0081, and the quick ratio declined from 0.57 to 0.12.
D
Sell
6/18/2020Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 6/18/2020 due to an increase in the valuation index, total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 6/18/2020 due to an increase in the valuation index, total return index and volatility index.
D
Sell
6/3/2020Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 6/3/2020 due to a major decline in the solvency index, valuation index and total return index.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 6/3/2020 due to a major decline in the solvency index, valuation index and total return index.
D
Sell
12/19/2019Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 12/19/2019 due to an increase in the growth index and valuation index. Operating cash flow increased 82.37% from -$547.8 to -$96.6, EBIT increased 5.62% from -$574.3 to -$542, and earnings per share increased from -$0.013 to -$0.0124.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 12/19/2019 due to an increase in the growth index and valuation index. Operating cash flow increased 82.37% from -$547.8 to -$96.6, EBIT increased 5.62% from -$574.3 to -$542, and earnings per share increased from -$0.013 to -$0.0124.
D
Sell
9/10/2019Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 9/10/2019 due to a major decline in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 9/10/2019 due to a major decline in the total return index and volatility index.
D
Sell
6/17/2019Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 6/17/2019 due to an increase in the total return index, volatility index and growth index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 6/17/2019 due to an increase in the total return index, volatility index and growth index.
D
Sell
5/31/2019Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 5/31/2019 due to a noticeable decline in the growth index, efficiency index and volatility index. Total capital declined 53.24% from $780 to $364.7.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to D- from D on 5/31/2019 due to a noticeable decline in the growth index, efficiency index and volatility index. Total capital declined 53.24% from $780 to $364.7.
D
Sell
4/1/2019Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 4/1/2019 due to a large increase in the growth index and efficiency index. Earnings per share increased from -$0.036 to -$0.0177, net income increased 42.55% from -$1.29M to -$740.7, and EBIT increased 40.61% from -$1.24M to -$735.7.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D from D- on 4/1/2019 due to a large increase in the growth index and efficiency index. Earnings per share increased from -$0.036 to -$0.0177, net income increased 42.55% from -$1.29M to -$740.7, and EBIT increased 40.61% from -$1.24M to -$735.7.
D
Sell
12/3/2018Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D- from E on 12/3/2018 due to an increase in the total return index.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to D- from E on 12/3/2018 due to an increase in the total return index.
E
Sell
10/3/2018Downgrade
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E from E+ on 10/3/2018 due to a decline in the volatility index and valuation index.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E from E+ on 10/3/2018 due to a decline in the volatility index and valuation index.
E
Sell
9/4/2018Upgraded
Cognetivity Neurosciences Ltd. (CGN) was upgraded to E+ from E on 09/04/2018.
Cognetivity Neurosciences Ltd. (CGN) was upgraded to E+ from E on 09/04/2018.
E
Sell
8/17/2018None
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E from U on 08/17/2018.
Cognetivity Neurosciences Ltd. (CGN) was downgraded to E from U on 08/17/2018.
